Health AI Central
Share:
Peer-Reviewed Publication
Nutr Metab Cardiovasc Dis2025;35(8):104029.August 1, 2025Journal Article

Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population.

Pingfeng Feng1, Junlong Qin2, Zhixin Chai1, Dong Wei1, Yajie Zhang1, Peiyun Wang1, Minghai Zhao1, Bingbing He3, Zhongyi Ling3, Xin Li4
1Department of Medical Laboratory, Nanfang Hospital Southern Medical University, Guangzhou, 510515, China.
2Medical Laboratory of ShenzhenLuohu Hospital Group, Shenzhen, 518005, China.
3Shenzhen Mindray Bio-Medical Electronics Co.LTD, Shenzhen, 518057, China.
4Department of Medical Laboratory, Nanfang Hospital Southern Medical University, Guangzhou, 510515, China. Electronic address: 766818985@qq.com.
PubMed DOI

Abstract

BACKGROUND AND AIM: N-terminal pro B-type natriuretic peptide (NT-proBNP) is a key biomarker for assessing cardiac function and hemodynamic stress. However, clinical guidelines lack clear recommendations on its utility in populations at risk of heart failure (HF), including those with hypertension, diabetes, or dyslipidemia. This study aimed to characterize the distribution of NT-proBNP levels in…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.